Department of Medical Biochemistry and Microbiology, Uppsala University, Box 582, SE-751 23 Uppsala, Sweden.
Mol Microbiol. 2010 Mar;75(5):1299-313. doi: 10.1111/j.1365-2958.2010.07057.x. Epub 2010 Feb 3.
Mutations in the fmt gene (encoding formyl methionine transferase) that eliminate formylation of initiator tRNA (Met-tRNA(i)) confer resistance to the novel antibiotic class of peptide deformylase inhibitors (PDFIs) while concomitantly reducing bacterial fitness. Here we show in Salmonella typhimurium that novel mutations in initiation factor 2 (IF2) located outside the initiator tRNA binding domain can partly restore fitness of fmt mutants without loss of antibiotic resistance. Analysis of initiation of protein synthesis in vitro showed that with non-formylated Met-tRNA(i) IF2 mutants initiated much faster than wild-type IF2, whereas with formylated fMet-tRNA(i) the initiation rates were similar. Moreover, the increase in initiation rates with Met-tRNA(i) conferred by IF2 mutations in vitro correlated well with the increase in growth rate conferred by the same mutations in vivo, suggesting that the mutations in IF2 compensate formylation deficiency by increasing the rate of in vivo initiation with Met-tRNA(i). IF2 mutants had also a high propensity for erroneous initiation with elongator tRNAs in vitro, which could account for their reduced fitness in vivo in a formylation-proficient strain. More generally, our results suggest that bacterial protein synthesis is mRNA-limited and that compensatory mutations in IF2 could increase the persistence of PDFI-resistant bacteria in clinical settings.
fmt 基因(编码甲酰甲硫氨酸转移酶)的突变消除了起始 tRNA(Met-tRNA(i))的甲酰化,从而赋予了对新型肽脱甲酰基酶抑制剂(PDFIs)类抗生素的抗性,同时降低了细菌的适应性。在这里,我们在鼠伤寒沙门氏菌中表明,位于起始 tRNA 结合域之外的起始因子 2 (IF2)的新突变可以部分恢复 fmt 突变体的适应性,而不会失去抗生素抗性。体外蛋白质合成起始分析表明,非甲酰化 Met-tRNA(i)时,IF2 突变体的起始速度比野生型 IF2 快得多,而甲酰化 fMet-tRNA(i)时,起始速度相似。此外,IF2 突变在体外赋予 Met-tRNA(i)起始速率的增加与相同突变在体内赋予的生长速率的增加很好地相关,表明 IF2 突变通过增加体内 Met-tRNA(i)的起始速率来补偿甲酰化不足。IF2 突变体在体外也具有与延伸 tRNA 错误起始的高倾向,这可以解释它们在甲酰化有效的菌株中适应性降低。更一般地,我们的结果表明细菌蛋白质合成受到 mRNA 的限制,IF2 中的补偿性突变可以增加 PDFI 抗性细菌在临床环境中的持久性。